BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: February 4, 2006
Last updated: November 7, 2015
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Estimated Primary Completion Date: No date given